Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MenABCWY vs Bexsero in Adolescents
NCT02212457Phase 2Completed
- Sponsor
- GSK
- Start
- Aug 2014
- Primary completion
- May 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 3
01
Overview
Phase 2, randomised, double-blind trial of Meningococcal ABCYW vaccine in meningococcal infection (6 arms), sponsored by GSK. Primary endpoint: Human Serum Bactericidal Assay Geometric Mean Titers Against N. Meningitidis Serogroup B Test Strains at Month 3. Started Aug 2014; status: completed.
02
Drugs
Meningococcal ABCYW vaccine
03
Conditions
meningococcal infection
Beyond the preview
Go deeper on NCT02212457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02212457.